CO4910131A1 - NEW SUBSTITUTED IMIDAZOLE COMPOUNDS - Google Patents

NEW SUBSTITUTED IMIDAZOLE COMPOUNDS

Info

Publication number
CO4910131A1
CO4910131A1 CO97000803A CO97000803A CO4910131A1 CO 4910131 A1 CO4910131 A1 CO 4910131A1 CO 97000803 A CO97000803 A CO 97000803A CO 97000803 A CO97000803 A CO 97000803A CO 4910131 A1 CO4910131 A1 CO 4910131A1
Authority
CO
Colombia
Prior art keywords
alkyl
substituted
integer
heterocyclyl
4alkyl
Prior art date
Application number
CO97000803A
Other languages
Spanish (es)
Inventor
Jerry I Adams
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Priority to CO97000803A priority Critical patent/CO4910131A1/en
Publication of CO4910131A1 publication Critical patent/CO4910131A1/en

Links

Abstract

Un compuesto representado por la fórmula (I):R1 es un anillo de 4-pirimidinilo sustituido con C1-4 alcoxi y es sustituido opcionalmente adicionalmente e independientemente por C1-4 alquilo, halógeno, hidroxil, C1-4 alcoxi, C1-4 alquiltio, C1-4 alquilsulfinilo, CH2 OR12 , amino, mono y di C1-6 alquilo amino sustituido, N(R10)C(O)Rc o un anillo de N-heterociclilo que tiene de 5 a 7 miembros y contiene opcionalmente un heteroátomo adicional seleccionado de oxígeno, azufre o NR15 ; R1 es fenilo, naft-1-il o naft-2-il, o un heteroarilo, opcionalmente sustituido por uno o dos sustituyentes, cada uno de los cuales es seleccionado independientemente, y que, para un sustituyente de 4-fenilo, 4-naft-1-il, 5-naft-2-il o 6-naft-2-il es halógeno, ciano, nitro (C(Z)NR7 R17 , C(Z)OR16 , (CR10 R20 )v COR12 , SR5 , SOR5 , OR12 C1-4 alquilo sustituido por halo, C1-4 alquilo, ZC(Z)R12 , NR10 C(Z)16 , o (CR10 R20 )vNR10 R20 y que para otras posiciones de sustitución, es halógeno, ciano, C(Z)NR13 R14 , C(Z)OR3 , (CR10 R20 )m"COR3 , S(O)mR3 , OR3 , C1-4 alquilo sustituido por halo, C1-4 alquilo, (CR10 R20 )m"NR10 C(Z)R3 , NR10 S(O)m´R8 , NR10 S(O)m´NR7 R17 , ZC(Z)R3 o (CR10 R20 )m"NR13 R14 ; n es un entero que tiene un valor de 1 a 10; m es 0, o el entero 1 ó 2; m´ es un entero que tiene un valor de 1 ó 2; m" es O, o un entero que tiene un valor de 1 a 5; v es 0, o un entero que tiene un valor de 1 ó 2; R2 es un heterociclilo opcionalmente sustituido, o un medio heterociclil C1-10 alquilo opcionalmente sustituido; Z es oxígeno o azufre; Rc es hidrógeno, C1-6 alquilo, C3-7 cicloalquilo, arilo, arilC1-4 alquilo, heteroarilo, heteroarilC1-4 alquilo, heterociclilo, o heterociclil C1-4 alquilo; R3 es heterociclilo, heterociclil C1-10 alquilo o R8 ; R5 es hidrógeno, C1-4 alquilo, C2-4 alquenilo,...A compound represented by formula (I): R1 is a C1-4alkoxy substituted 4-pyrimidinyl ring and is optionally additionally and independently substituted by C1-4alkyl, halogen, hydroxyl, C1-4alkoxy, C1-4alkylthio , C1-4 alkylsulfinyl, CH2 OR12, amino, mono and di C1-6 amino substituted alkyl, N (R10) C (O) Rc or an N-heterocyclyl ring having 5 to 7 members and optionally containing an additional heteroatom selected from oxygen, sulfur or NR15; R1 is phenyl, naphth-1-yl or naphth-2-yl, or a heteroaryl, optionally substituted by one or two substituents, each of which is independently selected, and which, for a 4-phenyl substituent, 4- naft-1-yl, 5-naft-2-yl or 6-naft-2-yl is halogen, cyano, nitro (C (Z) NR7 R17, C (Z) OR16, (CR10 R20) v COR12, SR5, SOR5, OR12 C1-4 alkyl substituted by halo, C1-4 alkyl, ZC (Z) R12, NR10 C (Z) 16, or (CR10 R20) vNR10 R20 and that for other substitution positions, is halogen, cyano, C (Z) NR13 R14, C (Z) OR3, (CR10 R20) m "COR3, S (O) mR3, OR3, C1-4 halo-substituted alkyl, C1-4 alkyl, (CR10 R20) m" NR10 C ( Z) R3, NR10 S (O) m´R8, NR10 S (O) m´NR7 R17, ZC (Z) R3 or (CR10 R20) m "NR13 R14; n is an integer that has a value from 1 to 10 ; m is 0, or the integer 1 or 2; m´ is an integer that has a value of 1 or 2; m "is O, or an integer that has a value from 1 to 5; v is 0, or an integer having a value of 1 or 2; R2 is an optionally substituted heterocyclyl, or a heterocyclic medium optionally substituted C 1-10 -alkyl; Z is oxygen or sulfur; Rc is hydrogen, C1-6alkyl, C3-7cycloalkyl, aryl, arylC1-4alkyl, heteroaryl, heteroarylC1-4alkyl, heterocyclyl, or heterocyclylC1-4alkyl; R3 is heterocyclyl, heterocyclyl C1-10 alkyl, or R8; R5 is hydrogen, C1-4 alkyl, C2-4 alkenyl, ...

CO97000803A 1997-01-10 1997-01-10 NEW SUBSTITUTED IMIDAZOLE COMPOUNDS CO4910131A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CO97000803A CO4910131A1 (en) 1997-01-10 1997-01-10 NEW SUBSTITUTED IMIDAZOLE COMPOUNDS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CO97000803A CO4910131A1 (en) 1997-01-10 1997-01-10 NEW SUBSTITUTED IMIDAZOLE COMPOUNDS

Publications (1)

Publication Number Publication Date
CO4910131A1 true CO4910131A1 (en) 2000-04-24

Family

ID=40933908

Family Applications (1)

Application Number Title Priority Date Filing Date
CO97000803A CO4910131A1 (en) 1997-01-10 1997-01-10 NEW SUBSTITUTED IMIDAZOLE COMPOUNDS

Country Status (1)

Country Link
CO (1) CO4910131A1 (en)

Similar Documents

Publication Publication Date Title
CO4950612A1 (en) NEW SUBSTITUTED IMIDAZOLE COMPOUNDS
AR006307A1 (en) SUBSTITUTED IMIDAZOLE 5-PIRIDINIL OR 5-PIRIMIDINIL COMPOUNDS, PHARMACEUTICAL COMPOSITION, USE OF SUCH COMPOUNDS TO PREPARE MEDICINES AND PROCEDURE FOR PREPARING SUCH COMPOUNDS.
CO4950624A1 (en) NEW SUBSTITUTED IMIDAZOLE COMPOUNDS
AR006720A1 (en) A COMPOUND DERIVED FROM HETERO-CYCLIC AZAHEXANE, ITS USE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION, PROCEDURE FOR PREPARING IT AND A PHARMACEUTICAL COMPOSITION THAT INCLUDES IT
NZ518144A (en) Piperazine Compounds
CY1106534T1 (en) AROMATIC SEXAMELATE CYCLIC COMPOUNDS CONTAINING NITROGEN
DOP2010000068A (en) SUBSTITUTED PIRAZOL DERIVATIVES
AR041867A1 (en) AGENT TO PREVENT OR TREAT NEUROPATHY
CO6251247A2 (en) IMIDAZOQUINOLINAS WITH IMMUNO-MODULATING PROPERTIES
CO5180568A1 (en) PHARMACEUTICAL COMPOUNDS, ESPECIALLY MUTILINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
BR9908850A (en) Bicycle [2.2.1] | heptanes and related compounds
TW200613297A (en) Pyrazole derivatives
SE0300956L (en) stabilizer Blends
DK0792641T3 (en) Use of estrogen antagonists and estrogen agonists to inhibit pathological conditions
AR015579A1 (en) PROPENONA-IMIDAZOL DERIVATIVES AND PROCEDURE FOR PREPARATION
CO5550398A2 (en) 7-AMINOTRIAZOLPIRIMIDINAS, PROCESS AND INTERMEDIATES FOR THEIR PREPARATION, COMPOSITIONS THAT INCLUDE THEM AND THEIR USE TO CONTROL DAMAGING FUNGES
AR072166A1 (en) PIPERIDINE DERIVATIVE AND ITS USE AS A SUPERIOR RENINA INHIBITOR
TR199901665T2 (en) 4-(3-Heterocyclyl-1-Benzoyl)pyrazole and its uses as herbicide
EA201000101A1 (en) DERIVATIVES OF PYRIMIDINE 934
CO5650231A2 (en) DERIVATIVES OF 1- (ALQUILAMINOALQUIL-PIRROLIDIN- / PIPERIDINIL) -2,2-DIFENYLACETAMIDE AS ANTAGONISTS OF THE MUSCARINIC RECEIVER, ITS SYNTHESIS PROCEDURE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
YU44998A (en) Pyrazole compounds, processes for their production and herbicides containing them
AR006747A1 (en) SUBSTITUTED PIRAZOL HERBICIDE COMPOUNDS, HERBICIDE COMPOSITION THAT UNDERSTANDS THEM AND METHOD OF APPLICATION THEREOF.
ES2321307T8 (en) USE OF DERIVATIVES OF 4-CIANO-NAFTALENO-1,8-DICARBOXIMIDE AND RELATED COMPOUNDS TO PROTECT ORGANIC MATERIAL FROM THE HARMFUL EFFECTS OF LIGHT.
ES8304536A1 (en) Chemical Compounds
DK304289A (en) BENZ DERIVATIVES